Nuvation Bio Inc. Announces Full Exercise of Greenshoe Option in $287.5 Million Convertible Senior Notes Offering
Nuvation Bio announced that underwriters have fully exercised their over-allotment option, increasing the aggregate principal amount of 0.75% Convertible Senior Notes due 2032 sold in the offering to $287.5 million. The company entered into additional capped call transactions with a cap price of $10.4580, which represents an 80% premium over the last reported sale price on June 25, 2026.
Key figures
- Deal Value Usd
- 287500000
- Cap price
- 10.458
- Cap premium
- 80.0%
- Coupon rate
- 0.75%
- Net proceeds
- $277.6 million
- Maturity year
- 2032
- Capped call cost
- $2.2 million
- Greenshoe principal
- $37.5 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.